Top Markets
#1 Black Phoenix Black Phoenix +367.76%
#2 Islamic Coin Islamic Coin +158.17%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.01%
#5 Akedo Akedo +34.74%
#6 BasedHype BasedHype +29.66%
#7 Acurast Acurast +29.41%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.07%
#9 Cryptopia Cryptopia +21.42%
#10 GoPlus Security GoPlus Security +21.39%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Immune Therapeutics, Inc. Immune Therapeutics, Inc.

Immune Therapeutics, Inc.

IMUN
Clasificación en acciones #41154
Immune Therapeutics, Inc. currently conducts no significant business... Immune Therapeutics, Inc. currently conducts no significant business operations. Formerly known as TNI BioTech, Inc., the company adopted its present name in October 2014. Its corporate headquarters are situated in Orlando, Florida.
Precio por acción
$0.08
Última sincronización: 2023-11-13
Capitalización bursátil
$38.70K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Immune Therapeutics, Inc. (IMUN)

Categoría

Healthcare
Ganancias de Immune Therapeutics, Inc. (IMUN)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Immune Therapeutics, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Immune Therapeutics, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE